The GLP is committed to full transparency. Download and review our 2019 Annual Report

Viewpoint: ‘Anti-GMO lobby’ campaign against AquAdvantage salmon won’t end as fish heads for American plates

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

It’s been an 11-year, $30 million regulatory journey for genetically modified salmon to end up on American plates, and it will take about another 18 months for that to happen.

Earlier this year, the Food and Drug Administration lifted an import alert that allowed Massachusetts-based AquaBounty Technologies to import roughly 150,000 eggs into Indiana from its facility in Prince Edward Island, Canada. The eggs arrived at an Indiana fish farm in late May and it will take about 18 months for the salmon to reach market weight between roughly eight to 10 pounds.

The battle over GMOs in the U.S. with “a well-funded anti-GMO lobby that’s created a lot of distrust at the consumer level so we face a different labeling requirement and expectation in the U.S.,” [Sylvia Wulf, president and CEO of AquaBounty] said. “But the product is …. safe for people to eat, it’s safe for the fish and it’s safe for the environment. ….”

Related article:  Are GMO critics more open to gene editing that targets plant and human diseases?

AquaBounty is faced with selling its salmon following years of derogatory language around the fish, which Wulf said is not scientifically correct and not fair to consumers. “Because what they have done is placed a false perception in the consumers mind,” she said.

Read full, original article: AquaBounty Salmon No Longer Swimming Up Regulatory Stream

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend